Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Castle Biosciences Sees FY Revenue $255M-$330M

Castle Biosciences Sees FY Revenue $255M-$330M

-Reuters

byMichael Horton

September 20, 2022

1 minute read

-Reuters

Why SL Green Realty Stock Popped Today

By Ryan Gustafson

June 26, 1:32 PM

SL Green Realty Corp (NYSE: SLG) shares are trading higher Monday after the company announced that it has sold its 49.9% interest in 245 Park Avenue to a U.S. affiliate of Mori Trust Co., Ltd. at a gross asset valuation of $2.0 billion.

SLG

Wells Fargo Maintains Overweight on Gartner, Raises Price Target to $387

By Benzinga Newsdesk

February 8, 10:33 AM

Wells Fargo analyst Seth Weber maintains Gartner (NYSE:IT) with a Overweight and raises the price target from $370 to $387.

ClearSign Technologies Collaboration Partner Narion Corp. Receives $250,000 SBIR Grant To Develop Flare Methane Sensor

By Happy Mohamed

July 13, 9:01 AM

ClearSign Technologies Corporation (NASDAQ:CLIR) ("ClearSign" or the "Company"), an emerging leader in industrial combustion and sensing technologies that improve energy, operational efficiency and

CLIR